Investment & Planning Opportunities

OneE Group have worked extensively with a specialist pharmaceutical company, to provide these ideas based on various transdermal drug delivery technologies:

• The technologies allow medical drugs to be delivered into the body through the skin rather than by injection or with a doctor’s appointment
• Testing is required to establish whether the technologies work with specific medical drugs
• Any expenditure on the testing should qualify for Research & Development (R&D) Tax Credits

We feel that these opportunities are a rare example of investment based planning with sensible tax benefits. Please confirm your attendance at our seminar to learn more about how you could be part of this great opportunity.

Friday 6th Feb 2015 at 10am, Adams & Moore House